Your tumor is genetically unique.
Your treatment should be too.

Targeted
Therapy
Finder

Chief Editor Spotlight

Keith T Flaherty MD

Department of Medicine
Harvard Medical School

See all chief editors

Melanoma Therapy Finder developed in partnership with the American Society of Clinical Oncology (ASCO)

See the Science

Learn more about the science inside CollabRx Therapy Finders

Get the backstory
on how and why
melanoma survivor
Jay M. Tenenbaum founded CollabRx

Targeting Cancer

Systems Cancer Medicine: Towards Realization of Predictive, Preventive, Personalized, and Participatory (P4) Medicine.

Genetic Sequencing Could Help Match Patients with Biomarker-Driven Cancer Trials, Treatments


Cancer Types Colorectal Cancer Lung Cancer Melanoma Skin Cancer	Drugs Vemurafenib in melanoma Xalkori in lung cancer	Types EGFR mutations in lung cancer BRAF in melanoma

© 2012 CollabRx, Inc. All rights reserved. CollabRx and the CollabRx logo are trademarks of CollabRx, Inc. Privacy Policy Terms of Use
*Advisors' involvement with this project is an academic/scholarly activity and does not carry financial compensation.

Your tumor is genetically unique. Your treatment should be too.

See the Science

Founder Story

Targeting Cancer

Your tumor is genetically unique.
Your treatment should be too.